Tafamidis meglumine Soft Capsules
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tafamidis meglumine Soft Capsules, covering 2025-07-30 to 2025-07-30. Get the full timeline:
Most recent: Clinical Trial Update: To Evaluate the Efficacy and Safety of Tafamidis Meglumine Soft Capsules in the Treatment of Adult Patients With Transthyretin Amyloid Polyneuropathy [Phase 4]